Jim Simons Talis Biomedical Corp Transaction History

Renaissance Technologies LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$0.44 - $0.54 $5,456 - $6,696	12,400 Added 29.18%	54,900 $26,000
Q1 2023 May 12, 2023	BUY	$0.48 - $0.64 $3,648 - $4,864	7,600 Added 21.78%	42,500 $21,000
Q4 2022 Feb 13, 2023	BUY	$0.45 - $11.67 $1,215 - $31,509	2,700 Added 8.39%	34,900 $16,000
Q3 2022 Nov 14, 2022	SELL	$0.7 - $10.79 $52,895 - $815,346	-75,565 Reduced 70.12%	32,200 $22,000
Q2 2022 Aug 12, 2022	BUY	$0.81 - $1.44 $73,845 - $131,280	91,167 Added 549.26%	107,765 $88,000
Q1 2022 May 13, 2022	BUY	$1.3 - $4.19 $21,577 - $69,545	16,598 New	16,598 $23,000

Ticker TLIS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 26,619,200
Market Cap $45.8M
Description
Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also offers Talis One COVID-19 Test System, which focuses on detection of SARS-CoV-2, the virus that causes COVID-19. ...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.